Janella Hudson1, Matthew B Schabath2,3,4, Julian Sanchez3,5, Steven Sutton6, Vani N Simmons1,3,4, Susan T Vadaparampil1,3, Peter A Kanetsky2,3, Gwendolyn P Quinn1,3. 1. Departments of Health Outcomes and Behavior, Moffitt Cancer Center 2. Departments of Cancer Epidemiology, Moffitt Cancer Center 3. Oncologic Science, Morsani College of Medicine, University of South Florida 4. Departments of dThoracic Oncology, Moffitt Cancer Center, Tampa, Florida 5. Departments of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, Florida 6. Departments of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida
Abstract
Background: The lesbian, gay, bisexual, transgender, queer/questioning (LGBTQ) population is at higher risk for multiple types of cancers compared with the heterosexual population. Expert NCCN panels lead the nation in establishing clinical practice guidelines addressing cancer prevention, early detection, and treatment of cancer sites and populations. Given the emergence of new data identifying cancer disparities in the LGBTQ population, this study examined the inclusion of medical and/or psychosocial criteria unique to LGBTQ within NCCN Guidelines. Methods: Data were collected for 32 of the 50 NCCN Guidelines. Results: NCCN panel members reported that neither sexual orientation (84%) nor gender identity (94%) were relevant to the focus of their guidelines; 77% responded that their panels currently do not address LGBTQ issues, with no plans to address them in the future. Conclusions: Greater consideration should be given to the needs of LGBTQ patients across the cancer care continuum. Given that research concerning LGBTQ and cancer is in its infancy, additional empirical and evidence-based data are needed to bolster further integration of LGBTQ-specific criteria into clinical care guidelines.
Background: The lesbian, gay, bisexual, transgender, queer/questioning (LGBTQ) population is at higher risk for multiple types of cancers compared with the heterosexual population. Expert NCCN panels lead the nation in establishing clinical practice guidelines addressing cancer prevention, early detection, and treatment of cancer sites and populations. Given the emergence of new data identifying cancer disparities in the LGBTQ population, this study examined the inclusion of medical and/or psychosocial criteria unique to LGBTQ within NCCN Guidelines. Methods: Data were collected for 32 of the 50 NCCN Guidelines. Results: NCCN panel members reported that neither sexual orientation (84%) nor gender identity (94%) were relevant to the focus of their guidelines; 77% responded that their panels currently do not address LGBTQ issues, with no plans to address them in the future. Conclusions: Greater consideration should be given to the needs of LGBTQ patients across the cancer care continuum. Given that research concerning LGBTQ and cancer is in its infancy, additional empirical and evidence-based data are needed to bolster further integration of LGBTQ-specific criteria into clinical care guidelines.
Authors: Gina Shetty; Julian A Sanchez; Johnathan M Lancaster; Lauren E Wilson; Gwendolyn P Quinn; Matthew B Schabath Journal: Patient Educ Couns Date: 2016-05-02
Authors: Dorothy A Machalek; Mary Poynten; Fengyi Jin; Christopher K Fairley; Annabelle Farnsworth; Suzanne M Garland; Richard J Hillman; Kathy Petoumenos; Jennifer Roberts; Sepehr N Tabrizi; David J Templeton; Andrew E Grulich Journal: Lancet Oncol Date: 2012-03-23 Impact factor: 41.316
Authors: Gwendolyn P Quinn; Julian A Sanchez; Steven K Sutton; Susan T Vadaparampil; Giang T Nguyen; B Lee Green; Peter A Kanetsky; Matthew B Schabath Journal: CA Cancer J Clin Date: 2015-07-17 Impact factor: 508.702
Authors: Charles S Kamen; Marilyn Smith-Stoner; Charles E Heckler; Marie Flannery; Liz Margolies Journal: Oncol Nurs Forum Date: 2015-01 Impact factor: 2.172
Authors: Eduardo J Santiago-Rodríguez; Natalie A Rivadeneira; Michelle A DeVost; Urmimala Sarkar; Robert A Hiatt Journal: Health Equity Date: 2022-09-01